Structure Therapeutics Inc. Sponsored ADR (GPCR)
(Delayed Data from NSDQ)
$36.62 USD
-1.70 (-4.44%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $36.60 -0.02 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | 21.74% |
ABR | 1.00 |
Earnings ESP
|
7.22% |
---|---|
Current Year | -0.79 |
Next Year | -0.52 |
EPS (TTM) | -0.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 500.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 500.00M |
Low Estimate | NA | NA | NA | 500.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.21 | -0.79 | -0.52 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.13 | -0.10 | -0.73 | 2.04 |
High Estimate | -0.13 | -0.10 | -0.59 | 2.04 |
Low Estimate | -0.24 | -0.28 | -0.89 | -1.39 |
Year ago EPS | -0.21 | -0.17 | -0.81 | -0.79 |
Year over Year Growth Est. | 9.52% | -23.53% | 2.47% | 35.11% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.21 | -0.79 | -0.52 |
7 Days Ago | -0.19 | -0.21 | -0.79 | -0.52 |
30 Days Ago | -0.20 | -0.21 | -0.86 | -0.43 |
60 Days Ago | -0.20 | -0.21 | -0.86 | -0.43 |
90 Days Ago | -0.24 | -0.25 | -0.94 | -0.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.25 | -0.77 | -0.88 |
Zacks Consensus Estimate | -0.19 | -0.21 | -0.79 | -0.52 |
Earnings ESP | 7.22% | -16.82% | 2.94% | -70.54% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.19 | -0.17 | -0.21 | NA |
Estimate | -0.23 | -0.21 | -0.21 | -0.22 | NA |
Difference | 0.05 | 0.02 | 0.04 | 0.01 | 0.03 |
Surprise | 21.74% | 9.52% | 19.05% | 4.55% | 13.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more